Design, synthesis and testing of novel phytopathogenic fungicides.
新型植物病原杀菌剂的设计、合成和测试。
基本信息
- 批准号:BB/N010051/1
- 负责人:
- 金额:$ 76.76万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2016
- 资助国家:英国
- 起止时间:2016 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Enzymes are proteins that facilitate the reactions that enable living organisms to acquire energy for growth, reproduction and maintenance. A key challenge in understanding the structure-function relationship of one such group of enzymes, the alternative oxidases (AOX), rests upon the identification of its substrate and inhibitor-binding site and its mechanism of action. A detailed knowledge of the nature of this binding site is important since it will reveal whether or not there is a common architecture that can be applied to substrate and inhibitor-binding sites in general and hence provide an insight into the mechanism of binding. More importantly, this knowledge will assist in the suitable rational design of phytopathogenic and anti-parasitic drugs that are specifically targeted to the alternative oxidase. The alternative oxidase is not only present in fungi and plants but also widespread amongst human parasites such as Trypanosoma brucei (the causative agent of African sleeping sickness), intestinal parasites such as Cryptosporidium parvum (responsible for an airborne intestinal infection cryptosporidiosis) and opportunistic human pathogens such as Candida albicans (causes candidiasis or 'thrush'). With respect to the role of AOX in fungi, the development of resistance to agrochemicals by plant fungal pathogens is an international problem that affects all major crops. Indeed fungicide resistance is an important factor in the successful cultivation of cereals in the UK. It is estimated that the UK market for fungicides in cereals is approximately £250M (worldwide $3bn) with winter wheat being the main crop. Fungicides are used against a number of diseases, the major one of winter wheat being caused by Septoria tritici. The main chemical classes of fungicides used to treat UK cereals include the sterol biosynthesis inhibitors. The most important and successful group of these fungicides that have proved effective in the control of plant pathogens are the strobilurin fungicides which are specifically targeted to the mitochondrial respiratory chain (Qo site) thereby inhibiting fungal respiration. Unfortunately resistance to this fungicide often develops resulting in an inability to control fungal pathogens through continued application. Although the mechanism for conferring resistance to Qo fungicides is still controversial there is growing evidence to suggest that the addition of inhibitors, such as azoxystrobin, to fungal pathogens results in a strong induction of the alternative oxidase (AOX). AOX is a mitochondrial terminal oxidase which by-passes the Qo site and is induced in all plants, fungal pathogens and protists following stress induction. We have previously demonstrated that fungal plant pathogens such as Septoria tritici, a fungus that causes major leaf spot diseases in wheat & the wheat "Take-all" fungus, Gaeumannomyces graminis var. tritici have the capacity to express AOX when treated with respiratory inhibitors thereby allowing a strobilurin-resistant respiratory pathway to develop which may account for the varying efficacy of strobilurin fungicides. The major objective of this study is to identify formulations containing novel compounds which inhibit the fungal alternative oxidase and/or the main respiratory chain thereby providing a technique for the effective control of fungal diseases in cereal crops. We have already designed a number of these compounds (PCT/GB2015/050148 & PCT/GB2013/051030) which have proved to be potent inhibitors of the Ash dieback fungus and have demonstrated that these compounds are also effective against Septoria tritici. We will express the fungal rAOX enzyme in a yeast which will enable us to not only to quickly screen the compounds inhibitory effectiveness but also through genetic manipulation of the fungal enzyme ascertain the extent to which the enzyme may become resistant to the compounds we have synthesised.
酶是一种促进反应的蛋白质,这些反应使生物能够获得生长、繁殖和维持所需的能量。要理解这类酶的结构-功能关系,一个关键的挑战是确定它的底物和抑制剂结合部位及其作用机制。对这个结合位点的性质的详细了解是重要的,因为它将揭示是否有一个共同的体系结构可以应用于底物和抑制剂结合位点,从而提供对结合机制的洞察。更重要的是,这一知识将有助于针对替代氧化酶的植物病原体和抗寄生虫药物的适当合理设计。这种替代氧化酶不仅存在于真菌和植物中,而且在人类寄生虫中也很普遍,例如布鲁氏锥虫(非洲昏睡病的病原体)、肠道寄生虫如微小隐孢子虫(导致空气传播的肠道感染隐孢子虫病)以及条件致病的人类病原体如白色念珠菌(导致念珠菌病或鹅口疮)。关于AOX在真菌中的作用,植物真菌病原菌对农用化学品的抗性是一个影响所有主要作物的国际问题。事实上,杀菌剂抗性是英国谷物种植成功的一个重要因素。据估计,英国谷物中的杀菌剂市场约为2.5亿GB(全球价值30亿美元),其中冬小麦是主要作物。杀菌剂被用来防治许多疾病,其中最主要的一种是由小麦黑粉病引起的。用于治疗英国谷物的杀菌剂的主要化学类别包括类固醇生物合成抑制剂。在这些已被证明有效控制植物病原菌的杀菌剂中,最重要和最成功的一类是球果菊酯类杀菌剂,它们专门针对线粒体呼吸链(QO位点),从而抑制真菌的呼吸。不幸的是,对这种杀菌剂往往产生抗药性,导致无法通过继续使用来控制真菌病原体。尽管对QO杀菌剂产生抗性的机制仍然存在争议,但越来越多的证据表明,在真菌病原菌中加入嘧菌酯等抑制剂会导致交替氧化酶(AOX)的强烈诱导。AOX是一种绕过QO位点的线粒体末端氧化酶,在胁迫诱导后在所有植物、真菌病原体和原生生物中都被诱导。我们以前已经证明了真菌植物病原体,如引起小麦主要叶斑病的真菌-小麦全蚀型真菌--小麦赤霉菌变种。当用呼吸抑制剂处理时,小黑麦具有表达AOX的能力,从而允许发展出对百菌灵具有抗药性的呼吸途径,这可能解释了百菌清杀菌剂的不同疗效。本研究的主要目的是确定含有抑制真菌交替氧化酶和/或主要呼吸链的新化合物的制剂,从而为有效控制谷类作物的真菌病害提供一种技术。我们已经设计了一些化合物(PCT/GB2015/050148和PCT/GB2013/051030),这些化合物已经被证明是对白蜡树枯萎病菌的有效抑制剂,并证明这些化合物对小麦黑粉病也有有效的抑制作用。我们将在酵母中表达真菌rAOX酶,这将使我们不仅能够快速筛选化合物的抑制效果,而且还可以通过对真菌酶的遗传操作来确定酶对我们合成的化合物的抗药性程度。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach.
- DOI:10.1007/s10822-020-00360-8
- 发表时间:2021-03
- 期刊:
- 影响因子:3.5
- 作者:Rosell-Hidalgo A;Young L;Moore AL;Ghafourian T
- 通讯作者:Ghafourian T
Degradation of mitochondrial alternative oxidase in the appendices of Arum maculatum.
- DOI:10.1042/bcj20200515
- 发表时间:2020-09-18
- 期刊:
- 影响因子:0
- 作者:Ito K;Ogata T;Seito T;Umekawa Y;Kakizaki Y;Osada H;Moore AL
- 通讯作者:Moore AL
Kinetic characterisation and inhibitor sensitivity of Candida albicans and Candida auris recombinant AOX expressed in a self-assembled proteoliposome system.
- DOI:10.1038/s41598-021-94320-3
- 发表时间:2021-07-20
- 期刊:
- 影响因子:4.6
- 作者:Copsey AC;Barsottini MRO;May B;Xu F;Albury MS;Young L;Moore AL
- 通讯作者:Moore AL
Gentamicin Affects the Bioenergetics of Isolated Mitochondria and Collapses the Mitochondrial Membrane Potential in Cochlear Sensory Hair Cells.
庆大霉素影响分离线粒体的生物能并破坏耳蜗感觉毛细胞中的线粒体膜电位。
- DOI:10.3389/fncel.2019.00416
- 发表时间:2019
- 期刊:
- 影响因子:5.3
- 作者:O'Reilly M
- 通讯作者:O'Reilly M
A Self-Assembled Respiratory Chain that Catalyzes NADH Oxidation by Ubiquinone-10 Cycling between Complex I and the Alternative Oxidase
通过泛醌-10 在复合物 I 和替代氧化酶之间循环催化 NADH 氧化的自组装呼吸链
- DOI:10.1002/ange.201507332
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Jones A
- 通讯作者:Jones A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anthony Moore其他文献
Dissociation constant (Kd) of Trypanosoma brucei alternative oxidase inhibitors and their trypanocidal activity
布氏锥虫替代氧化酶抑制剂的解离常数(Kd)及其杀锥虫活性
- DOI:
- 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Daniel Ken Inaoka;Tomoo Shiba;Tsuge Chiaki;Chou Rihe;Gen Takahashi;Satoshi Ueda;Yasutoshi Kido;Emmanuel Oluwadare Balogun;Kimitoshi Sakamoto;Takeshi Nara;Teruki Honma;Akiko Tanaka;Masayuki Inoue;Hiroyuki Saimoto;Anthony Moore;Shigeharu Hara - 通讯作者:
Shigeharu Hara
OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28
OPA1 编码一种动力相关的 GTP 酶,在与染色体 3q28 相关的常染色体显性视神经萎缩中发生突变
- DOI:
10.1038/79944 - 发表时间:
2000-10-01 - 期刊:
- 影响因子:29.000
- 作者:
Christiane Alexander;Marcela Votruba;Ulrike E.A. Pesch;Dawn L. Thiselton;Simone Mayer;Anthony Moore;Miguel Rodriguez;Ulrich Kellner;Beate Leo-Kottler;Georg Auburger;Shomi S. Bhattacharya;Bernd Wissinger - 通讯作者:
Bernd Wissinger
Work in progress — Using cognitive development approaches in teaching electrical engineering concepts
正在进行的工作——在电气工程概念教学中使用认知发展方法
- DOI:
10.1109/fie.2010.5673626 - 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
M. Mina;Anthony Moore - 通讯作者:
Anthony Moore
Evidence base for CMV retinitis screening of paediatric organ and bone marrow transplant patients
- DOI:
10.1016/j.jaapos.2011.12.061 - 发表时间:
2012-02-01 - 期刊:
- 影响因子:
- 作者:
Eva Gajdosova;Prashant Hiwarkar;Anthony Moore;William Moore;Ken Nischal;Clive Edelsten - 通讯作者:
Clive Edelsten
Additional enzymatic activities of glycerol kinase from Trypanosoma brucei
布氏锥虫甘油激酶的其他酶活性
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Emmanuel O. Balogun;Daniel Ken Inaoka;Tomoo Shiba;Yoh-Ichi Watanabe;Anthony Moore;Shigeharu Harada and Kiyoshi Kita - 通讯作者:
Shigeharu Harada and Kiyoshi Kita
Anthony Moore的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anthony Moore', 18)}}的其他基金
A commercial plan for the exploitation of a series of novel anti-AOX compounds and associated technology applications
开发一系列新型抗AOX化合物及相关技术应用的商业计划
- 批准号:
BB/T003200/1 - 财政年份:2019
- 资助金额:
$ 76.76万 - 项目类别:
Research Grant
The development of novel AOX inhibitors for the cacao pathogen Moniliophthora perniciosa
针对可可病原体 Moniliophthora perniciosa 的新型 AOX 抑制剂的开发
- 批准号:
BB/R005249/1 - 财政年份:2017
- 资助金额:
$ 76.76万 - 项目类别:
Research Grant
Probing the molecular basis of oxygen reduction by the alternative oxidases
探索替代氧化酶还原氧的分子基础
- 批准号:
BB/L022915/1 - 财政年份:2014
- 资助金额:
$ 76.76万 - 项目类别:
Research Grant
Characterisation of the quinone-binding site of the plant alternative oxidase
植物替代氧化酶醌结合位点的表征
- 批准号:
BB/E015328/1 - 财政年份:2007
- 资助金额:
$ 76.76万 - 项目类别:
Research Grant
相似国自然基金
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
- 批准号:82370976
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
- 批准号:82370902
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
- 批准号:32372856
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
- 批准号:82372203
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
环状RNA circ-PRKAA1调控肝癌细胞脂代谢重编程的研究
- 批准号:32000527
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
ALDH6A1缺损重塑糖脂代谢促进肝细胞癌发生的机制研究
- 批准号:91957109
- 批准年份:2019
- 资助金额:79.0 万元
- 项目类别:重大研究计划
新型滤波器综合技术-直接综合技术(Direct synthesis Technique)的研究及应用
- 批准号:61671111
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
双硅化合物反应及天然产物合成应用研究
- 批准号:21172150
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
新型M4受体选择性拮抗剂的研究
- 批准号:30973615
- 批准年份:2009
- 资助金额:32.0 万元
- 项目类别:面上项目
基于penicillide结构的类天然产物合成及其胆固醇酯转运蛋白抑制的研究
- 批准号:20872019
- 批准年份:2008
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Design and synthesis of a next generation glycobiology toolbox for cell surface labeling
用于细胞表面标记的下一代糖生物学工具箱的设计和合成
- 批准号:
10699270 - 财政年份:2023
- 资助金额:
$ 76.76万 - 项目类别:
BEYOND BURDEN: NEW TOOLS FOR TUBERCULOSIS ANTIBIOTICREGIMEN DESIGN
超越负担:结核病抗生素方案设计的新工具
- 批准号:
10667002 - 财政年份:2023
- 资助金额:
$ 76.76万 - 项目类别:
Design, synthesis, and characterization of Gs- and Gq-biased agonists of the Glucagon-like Peptide-1 Receptor (GLP-1R)
胰高血糖素样肽 1 受体 (GLP-1R) 的 Gs 和 Gq 偏向激动剂的设计、合成和表征
- 批准号:
10388640 - 财政年份:2022
- 资助金额:
$ 76.76万 - 项目类别:
Design, synthesis and testing of oxidatively robust inhibitors for cysteine proteases in SARS2 virus and poliovirus
SARS2 病毒和脊髓灰质炎病毒半胱氨酸蛋白酶的氧化稳健抑制剂的设计、合成和测试
- 批准号:
469286 - 财政年份:2022
- 资助金额:
$ 76.76万 - 项目类别:
Operating Grants
Precision Design of Antimicrobial Peptides Against Bacterial Infections
抗细菌感染抗菌肽的精密设计
- 批准号:
10708842 - 财政年份:2022
- 资助金额:
$ 76.76万 - 项目类别:
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
通过合理设计球形核酸增强黑色素瘤特异性免疫反应的癌症纳米技术 (IRCN) 创新研究
- 批准号:
10402178 - 财政年份:2022
- 资助金额:
$ 76.76万 - 项目类别:
Design, Synthesis and Efficacy of New Small Molecule Therapeutics to Impede Myotonic Dystrophy
预防强直性肌营养不良的新型小分子疗法的设计、合成和功效
- 批准号:
10612955 - 财政年份:2022
- 资助金额:
$ 76.76万 - 项目类别:
Precision Design of Antimicrobial Peptides Against Bacterial Infections
抗细菌感染抗菌肽的精密设计
- 批准号:
10522451 - 财政年份:2022
- 资助金额:
$ 76.76万 - 项目类别:
Design, synthesis and efficacy of new small molecule therapeutics to impede myotonic dystrophy
预防强直性肌营养不良的新型小分子疗法的设计、合成和功效
- 批准号:
10453985 - 财政年份:2022
- 资助金额:
$ 76.76万 - 项目类别:
Probing the rules of molecular recognition through the de novo design of proteins that bind small-molecule drugs.
通过从头设计结合小分子药物的蛋白质来探索分子识别的规则。
- 批准号:
10463468 - 财政年份:2022
- 资助金额:
$ 76.76万 - 项目类别:














{{item.name}}会员




